Valstar Preservative Free
Brand names,
Valstar Preservative Free
Analogs
Valstar Preservative Free
Brand Names Mixture
Valstar Preservative Free
Chemical_Formula
C34H36F3NO13
Valstar Preservative Free
RX_link
http://www.rxlist.com/cgi/generic2/rubicin.htm
Valstar Preservative Free
fda sheet
Valstar Preservative Free
msds (material safety sheet)
Valstar Preservative Free
Synthesis Reference
No information avaliable
Valstar Preservative Free
Molecular Weight
723.644 g/mol
Valstar Preservative Free
Melting Point
116-117oC
Valstar Preservative Free
H2O Solubility
insoluble
Valstar Preservative Free
State
Solid
Valstar Preservative Free
LogP
3.332
Valstar Preservative Free
Dosage Forms
Liquid
Valstar Preservative Free
Indication
Bladder cancer
Valstar Preservative Free
Pharmacology
When 800 mg Valstar was administered intravesically to patients with carcinoma in situ, Valstar penetrated into the bladder wall. The mean total anthracycline concentration measured in bladder tissue exceeded the levels causing 90% cytoxicity to human bladder cells cultured in vitro. During the two-hour dose-retention period, the metabolism of Valstar to its major metabolites N-trifluoroacetyladriamycin and N-trifluoroacetyladriamycinol was neglible. After retention, the drug was almost completely excreted by voiding the instillate. Mean percent recovery of Valstar, N-trifluoroacetyladriamycin, and total anthracyclines in 14 urine samples from six patients was 98.6%, 0.4%, and 99.0% of the total administered drug, respectively. During the two-hour dose-retention period, only nanogram quantities of Valstar were absorbed into the plasma.
Valstar Preservative Free
Absorption
No information avaliable
Valstar Preservative Free
side effects and Toxicity
No information avaliable
Valstar Preservative Free
Patient Information
Valstar Preservative Free
Organisms Affected
Humans and other mammals